Premium
Successful management of familial hemophagocytic lymphohistiocytosis by the JAK 1/2 inhibitor ruxolitinib
Author(s) -
Marois Louis,
Touzot Fabien,
Haddad Elie,
Fernandez Isabel,
Morin MariePaule,
De Bruycker Jean Jacques,
Duval Michel,
Cellot Sonia,
Teira Pierre,
Bittencourt Henrique,
Decaluwe Hélène
Publication year - 2021
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.28954
Subject(s) - hemophagocytic lymphohistiocytosis , ruxolitinib , medicine , pediatrics , immunology , bone marrow , myelofibrosis , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom